A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.
A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...
BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...
Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...
Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...
B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...
In a collaborative interdisciplinary study, Michael Mitchell of the School of Engineering and Applied Science, Wei Guo of the School of Arts & Sciences, and Drew Weissman of the Perelman School of ...
Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.
Unlike T cells, NK cells can identify and eliminate malignant cells ... which guide their progression from hematopoietic stem ...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...
The following is a summary of “Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback